Sangamo Therapeutics (SGMOQ) Asset Utilization Ratio (2011 - 2025)

Sangamo Therapeutics' Asset Utilization Ratio history runs 15 years deep, the most recent figure standing at 0.53 for Q4 2025.

• On a quarterly basis, Asset Utilization Ratio changed 0.0% year-over-year to 0.53 in Q4 2025; TTM through Dec 2025 was 0.53, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.49, up 13.2% from the prior year.
• Asset Utilization Ratio grew to 0.53 in Q4 2025 per SGMOQ's latest filing, from 0.34 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.92 in Q4 2023 and bottomed at 0.11 in Q2 2024.
• The 5-year median for Asset Utilization Ratio is 0.27 (2022), against an average of 0.39.
• Across the five-year window, Asset Utilization Ratio tumbled 80.62% in 2024 and surged 693.74% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.15 in 2021, then rose by 29.92% to 0.19 in 2022, then soared by 375.59% to 0.92 in 2023, then sank by 41.77% to 0.53 in 2024, then fell by 0.0% to 0.53 in 2025.
• Per Business Quant, the three latest SGMOQ Asset Utilization Ratio figures stand at 0.53 (Q4 2025), 0.34 (Q3 2025), and 0.88 (Q2 2025).